Chris, I also follow MNKD and have read the yahoo

Chris, I also follow MNKD and have read the yahoo board and your posts. We all know that MNKD's stock never took off as many had hoped and in fact has tanked since FDA approval and more after the Sanofi deal was announced. The same thing is happening with AMBS right now though there has been no big FDA approval or big deal announced. The company has strengthened its position and is on the verge of coming out with, what we hope, a breakthrough diagnostic kit but the stock is acting like it just came out with bad trial results. It could be pure manipulation but someone is selling and today's volume shows it wasn't just some retail investors who are impatient. I expect the stock to be volatile. What I don't expect is to have the company's CEO to over promise and under deliver. And I believe that is what he's doing. At what point will GC actually deliver concrete shareholder value? Will GC actually give us something of substance before or on Sept 22nd? I am not holding my breath. I do believe the future looks good at this point but you never know with biotechs. Things can always change on a dime. But I can tell you that if you or I said several months back that this stock would be trading under 9 cents on Sept 17th, we'd be called bashers, that we didn't know what the hell we were talking about and either get banned or ignored. But here we are. Under 9. I can bet you that Gerald and his team didn't think we'd be at this price point either. I think if Gerald had better chosen his words and wasn't as overly optimistic with what his prior expectations, I don't think we would be seeing the gyrations we are now seeing.

My Agenda: To see Amarantus prosper so I can make a nice return on my investment.